H.R. 747, introduced January 28, 2025 by Andy Barr (R-KY) with 9 cosponsors. Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs. 1 organization reported lobbying on it from January 2025 through September 2026.
Passage votes
1Near-unanimous
Organizations lobbying on it
1
Said where they stood
0of 1, in their reports
Cosponsors
9
What the bill does
The Congressional Research Service's summary of the bill as introduced in the House, January 28, 2025. The version Congress voted on may differ.
This bill subjects certain Chinese entities and government officials to potential sanctions related to opioid trafficking and requires the President to conduct certain preliminary analyses before regulating economic transactions in the event of a national emergency related to international drug trafficking.
Specifically, for the purposes of the Fentanyl Sanctions Act, the bill changes the definition of foreign opioid trafficker to specify that the term includes (1) Chinese entities involved in the production or sale of synthetic opioids or related pharmaceutical ingredients that fail to take steps to detect or prevent opioid trafficking; and (2) certain senior Chinese government officials that aid and abet opioid trafficking, including through intentional inaction. Under current law, the President must impose certain sanctions on individuals and entities identified as foreign opioid traffickers.
Further, the bill extends through 2029 an existing requirement that the President report to Congress annually on identified foreign opioid traffickers and any sanctions imposed on them. (This requirement expired in December 2024.)
The bill also requires the President to take additional steps in issuing regulations under the International Emergency Economic Powers Act (IEEPA) pursuant to a declared national emergency related to international drug trafficking. (IEEPA authorizes the President to regulate a variety of economic transactions following a declaration of national emergency.) Under the bill, the President must evaluate the costs and benefits of issuing economic regulations for the purpose of resolving the drug trafficking emergency and publish a discussion of such costs and benefits.
Each recorded vote on passing the bill, by party. Procedural votes (rules, motions to recommit, cloture) and amendments aren't shown: they mostly follow party lines whatever the bill says.
House, September 2, 2025 · Passage (two-thirds needed)
Organizations whose quarterly lobbying reports name H.R. 747, January 2025 through September 2026. Reports list what was lobbied on, not the position taken: an organization here may have backed the bill, opposed it, or wanted one part of it changed. None of 1 said which in the report. Reports don't break spending down by bill, so there's no dollar figure for this one.
Organizations whose lobbying reports name H.R. 747
Organization, and what its report says
Reports
Said
FDD Action
…H.R. 2012, Iran Sanctions Relief Review Act of 2025, all provisions. H.R. 747, Stop Chinese Fentanyl Act of 2025, all provisions. H.R.1474, International Nuclear Energy Financing Act of 2025, all…